Annual EBIT
-$56.24 M
+$18.47 M+24.72%
December 31, 2023
Summary
- As of February 8, 2025, VAXX annual earnings before interest & taxes is -$56.24 million, with the most recent change of +$18.47 million (+24.72%) on December 31, 2023.
- During the last 3 years, VAXX annual EBIT has fallen by -$17.46 million (-45.04%).
- VAXX annual EBIT is now -309.66% below its all-time high of -$13.73 million, reached on December 31, 2019.
Performance
VAXX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.21 M
+$1.76 M+13.56%
December 31, 2023
Summary
- As of February 8, 2025, VAXX quarterly earnings before interest & taxes is -$11.21 million, with the most recent change of +$1.76 million (+13.56%) on December 31, 2023.
- Over the past year, VAXX quarterly EBIT has increased by +$9.00 million (+44.52%).
- VAXX quarterly EBIT is now -63.79% below its all-time high of -$6.84 million, reached on June 30, 2020.
Performance
VAXX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$56.24 M
+$9.00 M+13.79%
December 31, 2023
Summary
- As of February 8, 2025, VAXX TTM earnings before interest & taxes is -$56.24 million, with the most recent change of +$9.00 million (+13.79%) on December 31, 2023.
- Over the past year, VAXX TTM EBIT has increased by +$18.47 million (+24.72%).
- VAXX TTM EBIT is now -721.73% below its all-time high of -$6.84 million, reached on June 30, 2020.
Performance
VAXX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VAXX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.7% | +44.5% | +24.7% |
| 3 y3 years | -45.0% | +8.7% | -59.5% |
| 5 y5 years | -309.7% | -63.8% | -721.7% |
VAXX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.8% | at high | +76.5% | at high | +58.8% |
| 5 y | 5-year | -309.7% | +58.8% | -63.8% | +76.5% | -721.7% | +58.8% |
| alltime | all time | -309.7% | +58.8% | -63.8% | +76.5% | -721.7% | +58.8% |
Vaxxinity EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$56.24 M(-24.7%) | -$11.21 M(-13.6%) | -$56.24 M(-13.8%) |
| Sep 2023 | - | -$12.97 M(-6.2%) | -$65.23 M(-8.7%) |
| Jun 2023 | - | -$13.83 M(-24.1%) | -$71.46 M(-4.4%) |
| Mar 2023 | - | -$18.23 M(-9.8%) | -$74.78 M(+0.1%) |
| Dec 2022 | -$74.71 M(-45.2%) | -$20.21 M(+5.3%) | -$74.71 M(-26.9%) |
| Sep 2022 | - | -$19.20 M(+12.0%) | -$102.25 M(-9.8%) |
| Jun 2022 | - | -$17.15 M(-5.6%) | -$113.33 M(-7.8%) |
| Mar 2022 | - | -$18.16 M(-62.0%) | -$122.98 M(-9.8%) |
| Dec 2021 | -$136.34 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$47.75 M(+57.7%) | -$136.33 M(+35.2%) |
| Sep 2021 | - | -$30.28 M(+13.0%) | -$100.86 M(+16.3%) |
| Jun 2021 | - | -$26.80 M(-15.0%) | -$86.72 M(+29.9%) |
| Mar 2021 | - | -$31.51 M(+156.7%) | -$66.76 M(+89.4%) |
| Dec 2020 | -$38.77 M(+182.5%) | - | - |
| Dec 2020 | - | -$12.27 M(-23.9%) | -$35.25 M(+53.4%) |
| Sep 2020 | - | -$16.13 M(+135.7%) | -$22.98 M(+235.7%) |
| Jun 2020 | - | -$6.84 M | -$6.84 M |
| Dec 2019 | -$13.73 M | - | - |
FAQ
- What is Vaxxinity annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vaxxinity?
- What is Vaxxinity annual EBIT year-on-year change?
- What is Vaxxinity quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vaxxinity?
- What is Vaxxinity quarterly EBIT year-on-year change?
- What is Vaxxinity TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vaxxinity?
- What is Vaxxinity TTM EBIT year-on-year change?
What is Vaxxinity annual earnings before interest & taxes?
The current annual EBIT of VAXX is -$56.24 M
What is the all time high annual EBIT for Vaxxinity?
Vaxxinity all-time high annual earnings before interest & taxes is -$13.73 M
What is Vaxxinity annual EBIT year-on-year change?
Over the past year, VAXX annual earnings before interest & taxes has changed by +$18.47 M (+24.72%)
What is Vaxxinity quarterly earnings before interest & taxes?
The current quarterly EBIT of VAXX is -$11.21 M
What is the all time high quarterly EBIT for Vaxxinity?
Vaxxinity all-time high quarterly earnings before interest & taxes is -$6.84 M
What is Vaxxinity quarterly EBIT year-on-year change?
Over the past year, VAXX quarterly earnings before interest & taxes has changed by +$9.00 M (+44.52%)
What is Vaxxinity TTM earnings before interest & taxes?
The current TTM EBIT of VAXX is -$56.24 M
What is the all time high TTM EBIT for Vaxxinity?
Vaxxinity all-time high TTM earnings before interest & taxes is -$6.84 M
What is Vaxxinity TTM EBIT year-on-year change?
Over the past year, VAXX TTM earnings before interest & taxes has changed by +$18.47 M (+24.72%)